European Union: Pharmaceuticals

1 min read

In a chapter in the newly released GCR Insight: Europe, Middle East and Africa Antitrust Review 2021, Antitrust/Competition partners James Killick, Assimakis Komninos, Axel Schulz, Strati Sakellariou-Witt and local partner Jérémie Jourdan cover the main developments in the pharmaceutical sector in the European Union over the period 2018–2020. To view the chapter, click here.


An extract from GCR's Europe, Middle East And Africa Antitrust Review 2021, first published in July 2020. The whole publication is available at


See also: United States: Pharmaceutical Antitrust 2021

This publication is provided for your convenience and does not constitute legal advice. This publication is protected by copyright.